CRYOPORT, INC. Income (Loss) from Continuing Operations, Per Diluted Share
CRYOPORT, INC. (CYRX) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.20 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-06
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was -$0.20.
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was -$0.23.
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was -$0.17, a 525.00% decline year-over-year.
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$0.28.
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for fiscal 2025 was -$0.84.
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$2.29.
- CRYOPORT, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$1.90.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.20 10-Q · filed 2026-08-06 | -$0.43 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$0.23 10-Q · filed 2026-05-05 | ||||
| 2025-12-31 | -$0.84 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$0.17 10-Q · filed 2025-11-06 | -$0.63 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$0.28 10-Q · filed 2026-08-06 | -$0.45 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$0.17 10-Q · filed 2026-05-05 | -$0.22 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | -$2.29 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $0.04 10-Q · filed 2025-11-06 | -$1.90 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$1.59 10-Q · filed 2025-08-12 | -$1.94 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | -$0.35 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | -$1.90 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |